Stockscreener 앱 받기
141.11
0.13%
-0.18
시간 외 거래:
141.12
0.010
+0.01%
Gilead Sciences Inc 주식(GILD)의 최신 뉴스
Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock - Yahoo Finance Singapore
Gilead Sciences, Inc. $GILD Shares Bought by Swiss Life Asset Management Ltd - MarketBeat
Investment Research Partners LLC Takes $928,000 Position in Gilead Sciences, Inc. $GILD - MarketBeat
Coldstream Capital Management Inc. Acquires 8,807 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (GILD) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance Australia
Ciara Is Bringing Back the Pop Culture PSA (Exclusive) - Cosmopolitan
Gilead Sciences to buy Arcellx in deal valued at $7.8 billion - MSN
Gilead Sciences initiates challenging study for aggressive breast cancer form - Traders Union
Antiretroviral Therapy Market Critical Analysis with Expert Opinion| Gilead Sciences, Viatris, AbbVie - openPR.com
Gilead Sciences Stock Performance vs. Business Health Analysis 2026News and Statistics - IndexBox
Danske Bank A S Takes $133.05 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Captrust Financial Advisors Has $211.80 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Purchased by Achmea Investment Management B.V. - MarketBeat
Gilead Sciences CFO Dickinson sells $432k in stock - Investing.com
Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares - MarketBeat
Insider Sell: Andrew Dickinson Sells Shares of Gilead Sciences I - GuruFocus
Gilead Sciences (NASDAQ:GILD) CFO Sells $432,690.00 in Stock - MarketBeat
Manta Cares and Gilead Sciences Announce Collaboration to Support Patients Navigating Metastatic Breast and Lung Cancer - Femtech Insider
Gilead Sciences ASCENT-04 regimen gains Category 1 status in updated NCCN guidelines - Traders Union
Manta Cares and Gilead Sciences Collaborate to Support Patients Navigating Metastatic Lung and Breast Cancer - PRWeb
Cantor Fitzgerald reiterates Gilead stock rating on Yeztugo sales - Investing.com
National Bank of Canada FI Has $161.14 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences Conference: 6-Month HIV Regimens, 12-Month PrEP, Livdelzi Expansion, Oncology Push - Yahoo Finance
Gilead Sciences at Barclays: CFO touts YEZTUGO launch, Arcellx deal and “long cycle” growth - MarketBeat
Fort Point Capital Partners LLC Sells 8,153 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
CSM Advisors LLC Sells 42,400 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Bank of Nova Scotia Sells 319,843 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal - The Motley Fool
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal - The Motley Fool
Gotham Asset Management Increases Gilead Sciences Stake - National Today
Gilead Sciences, Inc. (NASDAQ:GILD) Short Interest Down 15.7% in February - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Holocene Advisors LP - MarketBeat
Gotham Asset Management LLC Has $38.40 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Crawford Investment Counsel Inc. Decreases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. (GILD): Growth prospects backed by analyst upgrades - MSN
Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades - Insider Monkey
Capitolis Liquid Global Markets LLC Invests $40.40 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Calydon Capital Has $7.34 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Chevy Chase Trust Holdings LLC Has $70.93 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
California Public Employees Retirement System Has $447.80 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
BNP Paribas Has $7.71 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Grows Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Ameriprise Financial Inc. Buys 400,002 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Alliancebernstein L.P. Sells 258,213 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Wellington Management Group LLP Has $2.84 Billion Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Prudential PLC - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Oruka Therapeutics (ORKA), Radnet (RDNT) and Gilead Sciences (GILD) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Oruka Therapeutics (ORKA) and Gilead Sciences (GILD) - The Globe and Mail
Dodge & Cox Trims Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (NASDAQ:GILD) Upgraded at Wall Street Zen - MarketBeat
Precision Trading with Gilead Sciences Inc. (GILD) Risk Zones - Stock Traders Daily
'Manufacturing is access': How Gilead's early production moves set PrEP med Yeztugo up for success - Fierce Pharma
Analysts Set Expectations for Gilead Sciences Q1 Earnings - MarketBeat
Martingale Asset Management L P Decreases Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Invesco Ltd. Purchases 1,618,453 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
The Zacks Analyst Blog Oracle, T-Mobile, Gilead, and C&F Financial - Yahoo Finance Singapore
How Renewed Wall Street Optimism Around HIV, Oncology And IP Runway At Gilead Sciences (GILD) Has Changed Its Investment Story - finance.yahoo.com
Top Stock Reports for Oracle, T-Mobile & Gilead - Yahoo Finance
[Form 4] GILEAD SCIENCES, INC. Insider Trading Activity - Stock Titan
Gilead (NASDAQ: GILD) CEO granted RSUs, options; shares withheld for tax - Stock Titan
Stock Traders Purchase Large Volume of Call Options on Gilead Sciences (NASDAQ:GILD) - MarketBeat
HIV prevention efforts amplified through music at SXSW, Gilead Sciences asserts - Traders Union
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum And Mixed Fair Value Signals - simplywall.st
Gilead Sciences, Inc. $GILD Stake Boosted by SageView Advisory Group LLC - MarketBeat
Franklin Resources Inc. Decreases Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Bokf Na Raises Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead (NASDAQ:GILD) Institutional Focus Rises In Nasdaq 100 Index - Kalkine Media
HER2-Negative Metastatic Breast Cancer Market Expected to Transform Significantly Through 2034, According to DelveInsight | Genentech, AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene - StreetInsider
Gilead Sciences at Barclays Conference: Strategic Growth and Diversification - Investing.com
News | British Land and Royal London sign Gilead at Euston development - CoStar
Gilead’s US$7.8b Arcellx Deal Deepens Cell Therapy Diversification - simplywall.st
Gilead Sciences, Inc. $GILD Shares Sold by Mackenzie Financial Corp - MarketBeat
Magnetar Financial LLC Increases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
0.99%
0.33%
자본화:
|
볼륨(24시간):